Algorithm for Prophylactic Mesh Use in Emergency Laparotomy.

March 18, 2021 updated by: Alejandro Bravo Salva, Hospital del Mar

Prevention of Incisional Hernia in Emergent Laparotomy Using a Prophylactic Mesh Augmentation Protocol Algorithm.

Use of informed algorithm for patients selection of prophylactic mesh aplication after midline laparotomy in emergency surgery.

Study Overview

Status

Recruiting

Detailed Description

Midline laparotomy complications have a high rate. When midline laparotomy is performed complications rate is even higher. One of the commons complications is incisional hernia, reaching up to 40%- 50% of cases in High risk groups.

Prophylactic mesh use has been proved to be useful preventing midline laparotomy in elective surgery. Despite this, there is not enough data to recommend its use in emergency surgery.

Aim of the study is to investigate if use of an algorithm of informed decision for use of prophylactic mesh in emergency midline laparotomy reduces incisional hernia incidence.

Prospective cohort study of all consecutive midline laparotomy performed at our emergency surgery department. Compare correct application of algorithm outcomes versus non correct application.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Alejandro Bravo-Salva, M.D.
  • Phone Number: +34932483204
  • Email: abravo@psmar.cat

Study Locations

    • Catalonia
      • Barcelona, Catalonia, Spain, 08911
        • Recruiting
        • Hospital Del Mar
        • Contact:
          • Alejandro Bravo-Salva, M.D.
          • Phone Number: +34932483204
          • Email: abravo@psmar.cat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Emergency midline laparotomy.

Exclusion Criteria:

  • Surgical infection present at the moment of surgery.
  • Ventrla or incisional hernia present at the moment of laparotomy .
  • Open abdomen.
  • Preoperative American Society of Anesthesiologist score (ASA) of V.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Algorithm use for prphylactic mesh after emergency laparotomy
Patients with emergency surgery in whom algorithm for prophylactic mesh is use to help decide abdominal wall mesh reinforcement or not.
Use of an algorithm for prophylactic mesh implantation in high risk patients after emergency midline laparotomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incisional hernia
Time Frame: Durign first and second year of follow up
Diagnosis by clinical or image control of incicionsal hernia during follow up.
Durign first and second year of follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence os surgical site ocurrence complications
Time Frame: During first postoperative month.

Any surgical site ocurrence (SSO) complication will be registered and classified using Clavien-Dindo complication scale.

More common complications are:

  • Seroma: a localized accumulation of serous fluid in a part of the body, occurring most commonly as a complication of a surgical procedure.
  • Wound haemathoma: wound related swelling of blood.
  • Surgical site infection: infection that occurs after surgery in the part of the body where the surgery took place. Will be classified as superficial or deep infection.
  • Wound dehiscence: lack of cutaneous healing in surgical wound.
During first postoperative month.
Long term mesh related complications: chronic pain and mesh infection.
Time Frame: During first year of follow-up.

Chronic pain: is any pain which persists beyond the normal healing period of 12 weeks. Visual analoge scale will be used to measure it.

Mesh infection: Late-onset mesh infection is defined as acute inflammatory response in surgical area within months or years after operation. It is diagnosed by the presence of infection symptoms and imaging examinations.

During first year of follow-up.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global rate of complication.
Time Frame: Durign first month of postoperative follow up.
Any postoperative complication will be recorded and classified using Clavien-Dindo scale.
Durign first month of postoperative follow up.
Reintervention
Time Frame: During first postoperative month follow up.
A second or subsequent intervention quotations due to postoperative comlications.
During first postoperative month follow up.
Hospital readmission
Time Frame: During first postoperative month follow up.
Patient admission to a hospital within 30 days after being discharged from an earlier hospital stay
During first postoperative month follow up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

March 15, 2021

First Submitted That Met QC Criteria

March 18, 2021

First Posted (Actual)

March 19, 2021

Study Record Updates

Last Update Posted (Actual)

March 19, 2021

Last Update Submitted That Met QC Criteria

March 18, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CEIC2019/8240/I

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incisional Hernia of Midline of Abdomen

Clinical Trials on Prophylactic mesh implantation

3
Subscribe